Guardant Health, Inc.
GH
$41.93
-$2.12-4.81%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
3/29/2025
-
MarketBeat
5/7/2025
-
The Fly
5/6/2025
-
GuruFocus
5/6/2025
-
GuruFocus
5/6/2025
-
The Fly
5/5/2025
-
GuruFocus
5/5/2025
-
GuruFocus
5/5/2025
-
The Fly
5/5/2025
-
MarketBeat
5/4/2025
-
Ticker Report
5/4/2025
-
MarketBeat
5/3/2025
-
Tickeron - Stocks
5/3/2025
-
Ticker Report
5/3/2025
-
MarketBeat
5/3/2025
-
MarketBeat
5/3/2025
-
GuruFocus
5/2/2025
-
Simply Wall St
5/2/2025
-
Ticker Report
5/2/2025
-
MarketBeat
5/2/2025
-
TipRanks Financial Blog
5/2/2025
-
The Fly
5/1/2025
-
GuruFocus
5/1/2025
-
SeekingAlpha
5/1/2025
-
Seeking Alpha - Long Ideas
5/1/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, April 30, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
855 698 8887
Address
3100 Hanover Street
Palo Alto, CA 94304
Palo Alto, CA 94304
Country
Year Founded
Business Description
Sector
Industry
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing...
more